[go: up one dir, main page]

NO20083535L - Alfa-krystallinsk form av argininsaltet til perindopril, en prosess for dets fremstilling og farmasoytiske sammensetninger inneholdende dette - Google Patents

Alfa-krystallinsk form av argininsaltet til perindopril, en prosess for dets fremstilling og farmasoytiske sammensetninger inneholdende dette

Info

Publication number
NO20083535L
NO20083535L NO20083535A NO20083535A NO20083535L NO 20083535 L NO20083535 L NO 20083535L NO 20083535 A NO20083535 A NO 20083535A NO 20083535 A NO20083535 A NO 20083535A NO 20083535 L NO20083535 L NO 20083535L
Authority
NO
Norway
Prior art keywords
crystalline form
perindopril
preparation
pharmaceutical compositions
alpha
Prior art date
Application number
NO20083535A
Other languages
English (en)
Inventor
Gerard Coquerel
Loic Lefebvre
Jean-Claude Souvie
Pascale Authouart
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37022969&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20083535(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20083535L publication Critical patent/NO20083535L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SAMMENDRAG ?-KRYSTALLINSK FORM AV ARGININSALTET TIL PERINDOPRIL, EN PROSESS FOR DETS FREMSTILLING OG FARMASØYTISKE SAMMENSETNINGER INNEHOLDENDE DETTE Den ?-krystallinske formen til forbindelsen ifølge formel (I): karakterisert ved dens pulver røntgendiffraksjonsdiagram. Medikamenter.
NO20083535A 2006-02-28 2008-08-14 Alfa-krystallinsk form av argininsaltet til perindopril, en prosess for dets fremstilling og farmasoytiske sammensetninger inneholdende dette NO20083535L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0601748A FR2897866B1 (fr) 2006-02-28 2006-02-28 Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
PCT/FR2007/000335 WO2007099217A1 (fr) 2006-02-28 2007-02-26 FORME CRISTALLINE α DU SEL D'ARGININE DU PERINDOPRIL, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT

Publications (1)

Publication Number Publication Date
NO20083535L true NO20083535L (no) 2008-08-14

Family

ID=37022969

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083535A NO20083535L (no) 2006-02-28 2008-08-14 Alfa-krystallinsk form av argininsaltet til perindopril, en prosess for dets fremstilling og farmasoytiske sammensetninger inneholdende dette

Country Status (27)

Country Link
US (1) US7846961B2 (no)
EP (1) EP1989182B1 (no)
JP (1) JP5255454B2 (no)
KR (2) KR20120001818A (no)
CN (1) CN101389603B (no)
AU (1) AU2007220435B2 (no)
BR (1) BRPI0708278B8 (no)
CA (1) CA2644467C (no)
CY (1) CY1117753T1 (no)
DK (1) DK1989182T3 (no)
EA (1) EA014716B1 (no)
ES (1) ES2581982T3 (no)
FR (1) FR2897866B1 (no)
GE (1) GEP20125433B (no)
HR (1) HRP20160644T1 (no)
HU (1) HUE027898T2 (no)
MA (1) MA30276B1 (no)
ME (1) ME02456B (no)
MY (1) MY151035A (no)
NO (1) NO20083535L (no)
NZ (1) NZ570367A (no)
PL (1) PL1989182T3 (no)
RS (1) RS54754B1 (no)
SI (1) SI1989182T1 (no)
UA (1) UA89905C2 (no)
WO (1) WO2007099217A1 (no)
ZA (1) ZA200807024B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2318365T3 (pl) 2008-06-24 2016-02-29 Mylan Laboratories Ltd Nowe odmiany polimorficzne (L) argininianu peryndoprylu i sposoby ich wytwarzania
AU2009212902A1 (en) 2008-09-03 2010-03-18 Apotex Pharmachem Inc. Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
FR2985512B1 (fr) * 2012-01-05 2014-06-20 Servier Lab Procede de preparation du sel de l-arginine du perindopril
FR2985511B1 (fr) * 2012-01-05 2014-01-03 Servier Lab Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN103172696B (zh) * 2012-12-19 2014-12-17 宁波美诺华药业股份有限公司 一种γ晶型的培哚普利精氨酸盐的制备方法
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules
SI26268A (sl) 2021-11-18 2023-05-31 Zupet Rok Postopek za pripravo hidratirane oblike perindopril l-arginina
CN114149357B (zh) * 2021-12-29 2024-06-25 江苏嘉逸医药有限公司 一种γ晶型培哚普利精氨酸盐的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
FR2897865B1 (fr) 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
PL2318365T3 (pl) 2008-06-24 2016-02-29 Mylan Laboratories Ltd Nowe odmiany polimorficzne (L) argininianu peryndoprylu i sposoby ich wytwarzania

Also Published As

Publication number Publication date
MY151035A (en) 2014-03-31
SI1989182T1 (sl) 2016-07-29
US7846961B2 (en) 2010-12-07
NZ570367A (en) 2011-03-31
CA2644467A1 (fr) 2007-09-07
ZA200807024B (en) 2010-04-28
AU2007220435B2 (en) 2010-11-04
BRPI0708278A2 (pt) 2011-05-24
CA2644467C (fr) 2011-07-26
JP5255454B2 (ja) 2013-08-07
WO2007099217A1 (fr) 2007-09-07
BRPI0708278B8 (pt) 2021-05-25
KR20120001818A (ko) 2012-01-04
PL1989182T3 (pl) 2016-09-30
FR2897866B1 (fr) 2008-04-18
JP2009534295A (ja) 2009-09-24
EA014716B1 (ru) 2011-02-28
HK1129669A1 (en) 2009-12-04
CN101389603A (zh) 2009-03-18
BRPI0708278B1 (pt) 2021-03-02
EP1989182B1 (fr) 2016-04-13
DK1989182T3 (en) 2016-07-25
ES2581982T3 (es) 2016-09-08
AU2007220435A1 (en) 2007-09-07
RS54754B1 (sr) 2016-10-31
HUE027898T2 (en) 2016-10-28
HRP20160644T1 (hr) 2016-07-01
CY1117753T1 (el) 2017-05-17
EA200801777A1 (ru) 2009-02-27
EP1989182A1 (fr) 2008-11-12
MA30276B1 (fr) 2009-03-02
KR20080106948A (ko) 2008-12-09
UA89905C2 (ru) 2010-03-10
US20090203758A1 (en) 2009-08-13
CN101389603B (zh) 2012-07-04
FR2897866A1 (fr) 2007-08-31
ME02456B (me) 2017-02-20
GEP20125433B (en) 2012-03-26

Similar Documents

Publication Publication Date Title
NO20083535L (no) Alfa-krystallinsk form av argininsaltet til perindopril, en prosess for dets fremstilling og farmasoytiske sammensetninger inneholdende dette
MX2009000884A (es) Derivados de piridizinona.
NO20064588L (no) Delta d-krystallinsk form av ivabradin-hydroklorid, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende den
WO2007141283A3 (en) Salts and crystalline salt forms of an 2-indolinone derivative
NO20060946L (no) β-krystallinsk form av ivabradin-hydroklorid, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
WO2009155121A3 (en) Inhibitors of pi3 kinase
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
NO20090295L (no) Substituerte heteroarylderivater
WO2010108074A3 (en) Inhibitors of pi3 kinase
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
MX2010012390A (es) Derivados de indazoles sustituidos con fenilo o piridinilo.
UA96785C2 (uk) Заміщені похідні оксиндолу та їх застосування як лігандів рецептора вазопресину
NO20064596L (no) Delta-krystallinsk form av ivabradin-hydroklorid, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
EA200600323A1 (ru) γd-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ
TW200738653A (en) Anthranilamide/2-amino-heteroarene carboxamide derivatives
WO2007120374A3 (en) Anti-arenaviral compounds
WO2008006795A3 (en) Indole compounds
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
MY143557A (en) Beta-crystalline form of perindopril arginine salt, process for its preparation, and pharmaceutical compositions containing it
EA201000703A1 (ru) Производные пиразола в качестве ингибиторов 5-lo
UA106200C2 (uk) Заміщені похідні оксіндолу та їхнє застосування для лікування захворювань, залежних від вазопресину
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
WO2009071691A3 (de) Oxindol-derivate und ihre verwendung als medikament
IL191670A0 (en) Compounds for the inhibition of apoptosis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application